CJC-1295 No DAC + IPAMORELIN

CJC-1295 (No DAC) & Ipamorelin Blend

Overview The CJC-1295 (No DAC) and Ipamorelin blend is a premium, high-purity research peptide formulation engineered to facilitate advanced in-vitro studies on pulsatile growth hormone (GH) release. By combining two highly characterized compounds, this short-acting but potent synergistic blend provides researchers with an optimal model for investigating GH secretagogue pathways, cellular signaling, and potential regenerative mechanisms.

Key Components

• CJC-1295 (No DAC): A structurally modified analog of Growth Hormone-Releasing Hormone (GHRH). By omitting the Drug Affinity Complex (DAC), this variant maintains a truncated half-life. This allows researchers to accurately observe a more natural, pulse-based GH release profile that closely mimics physiological baseline states.

• Ipamorelin: A highly selective ghrelin receptor agonist distinguished by its targeted GH stimulation. Ipamorelin induces clean secretagogue activity without precipitating significant fluctuations in cortisol or prolactin levels, making it an essential tool for isolating hormone regulation and cellular recovery processes.

Core Features

• Precision-Engineered Synergy: Formulated to exact ratios to ensure consistent, reproducible results in complex GH-related assays and studies.

• Lyophilized for Peak Stability: Processed via advanced freeze-drying techniques to guarantee effortless reconstitution and an extended shelf-life under proper laboratory storage conditions.

• Targeted Pulsatile Activity: Specifically optimized for investigations monitoring short-term, physiological patterns of GH secretion.

⚠️ Intended Use & Safety Protocol

Strictly for Laboratory Research. This compound is entirely prohibited for human or animal consumption and is not approved for diagnostic, therapeutic, or clinical use. Procurement is restricted exclusively to qualified researchers, licensed analytical laboratories, and credentialed institutions.